| Literature DB >> 35276997 |
Ignacio Escribano-Ott1, Julio Calleja-González1, Juan Mielgo-Ayuso2.
Abstract
Using nutritional supplements is a widespread strategy among basketball players to ensure the appropriate provision of energy and nutrients to avoid certain complaints. Particularly in basketball, there is no consensus on the type, quantity or form of use in which these supplements should be administered. Therefore, the main aim of this systematic review is to highlight the ergo-nutritional aids that may be effective in basketball. A structured search was carried out following the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA®) guidelines in the Medline/PubMed and Web of Science, Cochrane Library, and Scopus databases until 31 December 2021; no year restriction was applied to the search strategy. There were no filters applied to the basketball players' level, gender, race, or age to increase the power of the analysis. The results of this systematic review have shown that the effective dose of caffeine to enhance anaerobic performance and the feeling of vigorousness and energy ranges from 3 to 6 mg·kg-1, showing more positive effects when is supplemented 60-75 min before exercise in the morning and in test-based task. On the other hand, vitamin E (ranging from 200 to 268 mg), vitamin D (10,000 IU) and EPA (2 g) may have a potential role in recovery and wellness. The primary limitation of this study is the scarcity of studies related to nutritional supplementation in basketball players. However, a major strength is that this is the first systematic review describing what ergo-nutritional aids may be specifically helpful for basketball. Despite the need for future studies, certain nutritional supplements may have promising advantages for basketball (long-term supplementation of nitrates for recovery), whereas others (β-alanine, sodium bicarbonate, and acute nitrate supplementation) might theoretically be regarded as not interesting for basketball, or even not recommended by the World Anti-Doping Agency (WADA) as bovine colostrum.Entities:
Keywords: basketball; caffeine; creatine; ergo-nutritional aid; performance; recovery; supplement; vitamin D
Mesh:
Substances:
Year: 2022 PMID: 35276997 PMCID: PMC8839588 DOI: 10.3390/nu14030638
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Selection of studies.
Figure 2Risk of bias summary: review authors’ judgements about each risk of bias item for each included study.
Figure 3Risk of bias domains traffic-light plot.
Figure 4From paper to podium matrix.
Summary of the studies analyzed (grouped by ergo-nutritional aid).
|
|
|
|
|
|
| |||
| Sekel et al. (2020) [ | College female and male ( | Quasi experimental | 5000 IU/day VIT D (capsule) |
| Sekel et al. (2020) [ | College female and male ( | Quasi experimental | 10,000 IU/day VIT D (capsule) |
| Ghiasvand et al. 2010 [ | Highly trained male ( | Double blind placebo control randomized | 400 IU VIT E (soft gel) |
| Ghiasvand et al. (2010) [ | Highly trained male ( | Double blind placebo control randomized | 2 g EPA + 400 IU VIT E (soft gel) |
| Naziroǧlu et al. (2010) [ | Elite male ( | Intervention control no placebo | VIT E 150 mg +VIT C 500 mg (gelatin capsule) |
| Schulpis et al. (2007) [ | College male ( | Intervention | 200 mg VIT E * |
| Schulpis et al. (2007) [ | Adolescent male ( | Intervention control no placebo | 200 mg VIT E * |
| Tsakiris et al. (2006) [ | Adolescent male ( | Intervention control no placebo | 200 mg VIT E * |
| Tsakiris et al. (2006) [ | Adolescent male ( | Intervention control no placebo | 200 mg VIT E * |
| Schröder et al. (2000) [ | Elite male ( | Placebo no control | 250 mg VIT C + 8 Mg VIT E + 150 mg VIT A (4/day/35/days) (capsule) |
| Barnes et al. (1961) [ | Adolescent male and female ( | Intervention control no placebo | Not determined * |
|
| |||
| Raya-González et al. (2021) [ | Elite male ( | Double blind placebo control randomized | 6 mg·kg−1(60 min before) (liquid form) |
| Stojanovic et al. (2021) [ | Adolescent male ( | Double blind placebo control | 3 mg·kg−1 (60 min before) (capsule) |
| Tan et al. (2020) [ | Elite male ( | Randomized controlled trial | 6 mg·kg−1 (60 min before) (CAF powder dissolved in water) |
| Stojanovic et al. (2019) [ | Elite female ( | Double blind placebo control | 3 mg·kg−1 (60 min before) (capsule) |
| Scanlan et al. (2019) [ | Elite male ( | Double blind placebo control randomized | 3 mg·kg−1 (60 min before) (capsule) |
| Puente et al. (2017) [ | Elite male ( | Double blind placebo control randomized | 3 mg·kg−1 (75 min before) (capsule) |
| Cheng-Feng (2016) [ | College male ( | Double blind no control randomized | 6 mg·kg−1 (60 min before) (capsule) |
| Abian-Vicen et al. (2014) [ | College male ( | Double blind placebo control | 3 mg·kg−1 (60 min before) (energy drink powder) |
| Tucker et al. (2013) [ | Elite male ( | Placebo no control | 3 mg·kg−1 (60 min before) (Tablet) |
|
| |||
| Skarpa et al. (2020) [ | Elite female ( | Intervention control no placebo | 3.2 g BC twice a day for 24 weeks (capsules) |
| Feng-Ho et al. (2018) [ | Elite male ( | Randomized counterbalanced | 600 mL drink (6.25 kcal/kg; 36% PRO; 58% CHO; 6% FAT) (beverage) |
| Taylor et al. (2015) [ | College female ( | Placebo no control | 24 g (Whey PRO)/8 weeks/pre and post training (Powder) |
| Ronghui et al. (2015) [ | College male ( | Intervention control no placebo | 20 g (whey PRO) + OLI 40 g every two days (Powder) |
| Wilborn et al. (2013) [ | College female and male ( | Double blind no control randomized | 24 g (whey PRO)/8 weeks/pre and post training (Powder) |
| Wilborn et al. (2013) [ | College female and male ( | Double blind no control randomized | 24 g (casein PRO)/8 weeks/pre and post training (Powder) |
|
| |||
| Carvalho-Bruno et al. (2011) [ | Adolescent male ( | Crossover design placebo control | 8% CHO (beverage) |
| Baker et al. (2007) [ | Highly trained male ( | Intervention control placebo | 6% CHO (beverage) |
| Dougherty et al. (2006) [ | Adolescent ( | Double blind control placebo | 6% CHO and 18.0 mmol·L−1 Na(beverage) |
| Shi et al. (2005) [ | Highly trained male ( | Intervention control no placebo | Commercial drink (100 g/L) 500 mL/day(beverage) |
| Shi et al. (2005) [ | Highly trained male ( | Intervention control no placebo | 20 g CHO (beverage) + 20 CR (powder) for 7 days |
|
| |||
| López-Samanes et al. (2020) [ | Adolescent male ( | Double blind placebo control | 140 mL beetroot juice (12.8 mmol NO3) (beverage) |
| Chang et al. (2007) [ | Elite male ( | Intervention control no placebo | 200 g/day sweet potato leaf (solid meal) |
|
| |||
| Ansdell et al. (2020) [ | Highly trained male ( | Placebo no control | 0.2 g/kg (90 min before) + 0.2 g/kg (60 min before) (powder) |
| Gregg Afman et al. (2014) [ | College male ( | Randomized counterbalanced | 0.2 g/kg (90 min before) + 0.2 g/kg (20 min before) (powder) |
|
| |||
| Ghiasvand et al. (2010) [ | Highly trained male ( | Double blind placebo control randomized | 2 g EPA (soft gel) |
|
| |||
| Milioni et al. (2017) [ | College male ( | Placebo no control | 6.4 g/day (capsule) |
|
| |||
| Tsakiris et al. (2006) [ | College male ( | Intervention control no placebo | 0.5 g 24 h−1 for 30 days (powder) |
|
| |||
| Córdova-Martínez et al. (2021) [ | Elite male ( | Double-blind, placebo-controlled trial | 6 g/day (20 days) (capsule) |
|
| |||
| Córdova Martínez et al. (2017) [ | Elite male ( | Longitudinal no control no placebo | 400 mg/day (complete season) * |
Legend: Caffeine (CAF); Carbohydrate (CHO); Creatine (CRE); Protein (PRO); Vitamin (Vit); Eicosapentaenoic Acid (EPA); Beta Alanine (β-ALA); Cysteine (CYS); Glutamine (GLUT); Magnesium (MG); Nitrates (NIT); Sodium Bicarbonate (SB); International Units (IU); * Form of use not detailed.
(1) Ergo-nutritional aids for the on-court performance (anaerobic and aerobic outcomes). (2) Ergo-nutritional aids for the on-court performance (strength and body composition).
|
| |||
|
|
|
|
|
| CAF | 3 mg·kg−1 (60–75 min before) |
Sprint without ball (t) |
→+++ |
| 3–6 mg·kg−1 (60–75 min before) |
Agility Run (m/s) CMJ (cm) COD Without Ball (t) |
→++ →+++ ++ | |
| 6 mg·kg−1 (60–75 min before) |
Work Done Above End-Test Power (Kj) RSA (t) |
+ ++ | |
| β-ALA | 6.4 g/day (6 weeks) |
RSA (t) Peak Blood Lactate Concentration (mmol/L) |
+ + |
| CHO | Beverage (6–8% CHO) |
RSA (t) Skill performance |
→ → |
| SB | 0.2 g/kg (90 min before) + 0.2 g/kg (20 min before) |
RSA (t) Peak Blood Lactate Concentration (mmol/L) |
+ + |
| 0.2 g/kg (90 min before) + 0.2 g/kg (60 min before) |
RSA (t) Skill Performance |
→ → | |
| PRO | Whey PRO |
Agility (m/s) CMJ (cm) Broad Jump (D) |
++ ++ ++ |
| Casein PRO |
Agility (m/s) CMJ (cm) Broad Jump (D) |
+ + + | |
| 600 mL beverage (6.25 kcal/kg; PRO: 36%; CHO: 58%; fat: 6% in total calorie) |
Sprint without ball (t) |
→+++ | |
| 250 mL whole milk + 20 g whey PRO + 40 g oligosaccharides |
Agility Run (m/s) CMJ (cm) COD without ball (m/s) |
→++ →+++ ++ | |
|
| |||
|
|
|
|
|
| PRO | Whey PRO |
Strength upper body (1RM-Kg) Strength lower body (1RM-Kg) Body fat (%) Lean mass (kg) |
++ ++ ++ |
| Casein PRO |
Strength upper body (1RM-Kg) Strength lower body (1RM-Kg) Body fat (%) Lean mass (Kg) |
+ + + | |
Legend: Caffeine (CAF); Beta Alanine (β-ALA); Carbohydrate (CHO); Sodium Bicarbonate (SB); Protein (PRO); Counter Movement Jump (CMJ); Change of Direction (COD); Repeated Sprint Ability (RSA). Neutral effect (→); Positive Effect (+). Legend: Protein (PRO); Repetition Maximum (RM).
Ergo-nutritional aids for game recovery.
| Ergo-Nutritional Aid | Intervention Dose (Administration) | Outcome | Results |
|---|---|---|---|
| CRE | 20 g/day (7 days) + 2 g/d |
Blood Urine Nitrogen (mmol/L) |
+ |
| CRE+CHO (OLI) | 20 g/day CRE (7 days) + 20 CHO/day |
Blood Urine Nitrogen (mmol/L)) |
+ |
|
CK (U/L) |
+ | ||
| EPA | 2 g/day (6 weeks) |
MDA (nmol/L) |
+ |
| GLUT | 6 g/day (20 days) |
AST (U/L) Lymphocytes (%) |
+ + |
| MG | 400 mg/day (complete season) |
ALD (U/L) |
+ |
|
ALT (U/L) |
+ | ||
|
CK (U/L) |
+ | ||
| NIT | 200 g/day sweet potato leaf |
Total Antioxidant Status (mmol/L) Plasma polyphenol levels mg GAE/dL) |
+ + |
| CHO (OLI) | 500 mL beverage (100 g/mL) |
Blood Urine Nitrogen (mmol/L) |
+ |
|
CK (U/L) |
+ | ||
| CYS | 0.5 g/day (one month) |
CK (U/L) |
+ |
|
DNA Oxidative Damage (8-OHdG (ng mL−1)) |
+ | ||
|
LDH (U/L) |
+ | ||
|
Total Antioxidant Status (mmol/L) |
+ | ||
| PRO + CHO | 250 mL whole milk + 20 g whey PRO + 40 g oligosaccharides (once every two days) |
Hemoglobin (g/dl) RBCC (cells/mcL) Hematocrit (%) MCV (fl) |
+ + + + |
| VIT D | 10,000 IU/day (5 months) |
25(OH)D Status |
→ |
| 5000 IU/day (5 months) |
25(OH)D Status |
- | |
| VIT E + EPA | 400 IU VIT E+ 2 g EPA (6 weeks) |
Glutathione Reductase (u/L) |
+ |
|
TNF-α(pg/mL) |
+ | ||
|
IL-2 (pg(mL) |
+ | ||
| VIT C + E | 500 mg VIT C + 150 mg VIT E/Day (One Month) |
GSH-Px (IU/g protein) |
+ |
|
LP (umol/g protein) |
+ | ||
| VIT C + E + A | 250 mg VIT C + 8 mg VIT E + 150 mg VIT A |
Testosterone/Cortisol (pg mL−1) |
→ |
|
LDH (U/L) |
→ | ||
| VIT E | 200 mg/Day (One Month) |
Total Antioxidant Status (mmol/L) |
+++ |
|
Protein S100B (ug/L) |
+ | ||
|
Acetylcholinesterase (ΔOD/min/mg protein) |
+ | ||
|
DA, A, NA (pmol−1) |
+ | ||
| 400 IU (6 Weeks) |
Catalase Activity (U/mg) |
+ | |
| BC | Define As “Ilegal” (WADA) | ||
Legend: Creatine (CRE); Oligosaccharide (OLI); Eicosapentaenoic Acid (EPA); Glutamine (GLUT); Magnesium (MG); Nitrates (NIT); Cysteine (CYS); Carbohydrate (CHO), Vitamin (VIT); Bovine Colostrum (BC); International Units (IU); World Anti-Doping Agency (WADA); Creatine Kinase (CK); Serum Malondialdehyde level (MDA); Aldolase (ALD); Aspartate Aminotransferase (AST); Alanine Aminotransferase (ALT); Creatine Kinase (CK); Lactate Dehydrogenase (LDH); Red Blood Cell Count (RBCC); Mean Corpuscular Volume (MCV); Hidroxi (OH); Tumor Necrosis Factor-alpha (TNF-α); Interleukin-2 (IL-2) Glutathione Peroxidase (GSH-Px); Lipid Peroxidation (LP); Dopamine (DA); Adrenaline (A); Noradrenaline (NA); Neutral effect (→); Positive Effect (+); Negative Effect (-).